MDMA-assisted Cognitive Processing Therapy (MDMA-aCPT) + MIDOMAFETAMINE for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 May 2023: Trial registered, NCT05837845
  2. 10 Feb 2025: Trial started, NCT05837845

The trials

NCT05837845: MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy for Veterans With Severe Posttraumatic Stress Disorder

State
Under way
Phase
Phase 2
People
30 planned
Started
10 Feb 2025
Primary completion
May 2027
Arms
MDMA-assisted Cognitive Processing Therapy (MDMA-aCPT)
Results
None posted
  1. 1 May 2023: Trial registered
  2. 10 Feb 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.